These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30232538)

  • 21. Primary non-adherence to bisphosphonates in an integrated healthcare setting.
    Reynolds K; Muntner P; Cheetham TC; Harrison TN; Morisky DE; Silverman S; Gold DT; Vansomphone SS; Wei R; O'Malley CD
    Osteoporos Int; 2013 Sep; 24(9):2509-17. PubMed ID: 23595561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project.
    Morell S; Hemmeler C; Amsler F; Gross T
    Swiss Med Wkly; 2017; 147():w14451. PubMed ID: 28695555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.
    Seuffert P; Sagebien CA; McDonnell M; O'Hara DA
    Arch Osteoporos; 2016; 11():10. PubMed ID: 26847628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
    Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
    Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures.
    Schousboe JT; Dowd BE; Davison ML; Kane RL
    Osteoporos Int; 2010 Nov; 21(11):1899-909. PubMed ID: 19967337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective evaluation of persistence in osteoporosis therapy with oral bisphosphonates in Italy: the TOBI study.
    Gonnelli S; Caffarelli C; Letizia Mauro G; Di Munno O; Malavolta N; Migliaccio S; Nuti R
    Aging Clin Exp Res; 2019 Nov; 31(11):1541-1547. PubMed ID: 31030419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
    Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
    Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
    Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a 12-month analysis.
    Inderjeeth CA; Raymond WD; Briggs AM; Geelhoed E; Oldham D; Mountain D
    Osteoporos Int; 2018 Aug; 29(8):1759-1770. PubMed ID: 29704027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions.
    Beaupre LA; Majumdar SR; Dieleman S; Au A; Morrish DW
    Osteoporos Int; 2012 Feb; 23(2):573-80. PubMed ID: 21380637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Merle B; Chapurlat R; Vignot E; Thomas T; Haesebaert J; Schott AM
    Osteoporos Int; 2017 May; 28(5):1549-1558. PubMed ID: 28246884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population-based study of postfracture care in Manitoba, Canada 2000/2001-2014/2015.
    Cui Y; Lix LM; Yang S; Morin SN; Leslie WD
    Osteoporos Int; 2019 Oct; 30(10):2119-2127. PubMed ID: 31267162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis.
    Lai PS; Chua SS; Chan SP
    Int J Clin Pharm; 2013 Aug; 35(4):629-37. PubMed ID: 23677816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Coaching to Improve Osteoporosis Therapy Adherence: A Single Arm Variation of the C-STOP Study.
    Ye C; McAlister FA; Bellerose D; Lin M
    J Bone Metab; 2024 Feb; 31(1):13-20. PubMed ID: 38485237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Gupta MJ; Shah S; Peterson S; Baim S
    Osteoporos Int; 2018 Aug; 29(8):1861-1874. PubMed ID: 29869038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients.
    Morizio P; Burkhart JI; Ozawa S
    Ann Pharmacother; 2018 Oct; 52(10):1031-1041. PubMed ID: 29616561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study.
    Clemens KK; Jeyakumar N; Ouédraogo AM; Thain J; Khan T
    Arch Osteoporos; 2020 Aug; 15(1):133. PubMed ID: 32816151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
    Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial.
    Osaki M; Okuda R; Saeki Y; Okano T; Tsuda K; Nakamura T; Morio Y; Nagashima H; Hagino H
    Osteoporos Int; 2021 Mar; 32(3):495-503. PubMed ID: 33483796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.